Literature DB >> 16739314

Location and age at onset of colorectal cancer in Hungarian patients between 1993 and 2004. The high number of advanced cases supports the need for a colorectal cancer screening program in Hungary.

Peter Fuszek1, Henrik Csaba Horvath, Gabor Speer, Janos Papp, Petra Haller, Simon Fischer, Judit Halasz, Balazs Jaray, Eszter Szekely, Zsuzsanna Schaff, Andras Papp, Attila Bursics, Laszlo Harsanyi, Peter Lukovich, Peter Kupcsulik, Erika Hitre, Peter Laszlo Lakatos.   

Abstract

BACKGROUND: In recent decades, the incidence of proximal colorectal cancer (CRC) in North America and Western Europe has steadily increased, while that of the distal tumors has shown a corresponding decrease. Our aim was to investigate the change in age at diagnosis, the gender, location and cancer stage of CRC cases over the last 12 years in a large number of Hungarian patients. PATIENTS AND METHODS: The clinical and histological data of 1694 CRC patients (M/F: 917/777, age at diagnosis: 65.2 +/- SD 12.5 years), diagnosed at the First Department of Medicine and the First Department of Surgery of Semmelweis University, Budapest, Hungary, between January 1, 1993 and December 31, 2004, were analyzed retrospectively.
RESULTS: CRCs were rectal or left-sided in 70% and proximal (transverse, ascending or cecum) in 30% of the cases. The proportion of rectal carcinomas increased over the observed period (1993-1998: 31.6% vs. 1999-2004: 42.1%, p=0.001), while the proportion of proximal tumors remained stable. Eleven percent of CRCs were diagnosed under the age of 50 years. The age at diagnosis did not differ between males and females, but was lower in patients with rectal tumors compared to other localizations (p=0.02); 75.7% of the CRCs were T3-T4 at diagnosis and lymph node metastases could be detected in 47.7%.
CONCLUSION: In contrast to Western European and North American trends, the proportion of proximal CRCs did not increase in Hungary over the observed period. Almost two-thirds of all cancers were left-sided. The high percentage of locally advanced tumors and lymph node metastases supports the need for colorectal screening programs.

Entities:  

Mesh:

Year:  2006        PMID: 16739314

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies.

Authors:  Peter-Laszlo Lakatos; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

2.  Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis.

Authors:  Bernhard W Renz; Wolfgang E Thasler; Gerhard Preissler; Tobias Heide; Philippe N Khalil; Michael Mikhailov; Karl-Walter Jauch; Martin E Kreis; Markus Rentsch; Axel Kleespies
Journal:  J Gastrointest Surg       Date:  2013-03-09       Impact factor: 3.452

3.  Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.

Authors:  László Herszényi; Ferenc Sipos; Orsolya Galamb; Norbert Solymosi; István Hritz; Pál Miheller; Lajos Berczi; Béla Molnár; Zsolt Tulassay
Journal:  Pathol Oncol Res       Date:  2008-03-18       Impact factor: 3.201

4.  Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients.

Authors:  Peter Laszlo Lakatos; Erika Hitre; Ferenc Szalay; Kerstin Zinober; Peter Fuszek; Laszlo Lakatos; Simon Fischer; Janos Osztovits; Orsolya Gemela; Gabor Veres; Janos Papp; Peter Ferenci
Journal:  BMC Cancer       Date:  2007-03-27       Impact factor: 4.430

5.  Age and site of Colonic Neoplastic Lesions: Implications of screening in South Asia.

Authors:  Manzoor Hussain; Abdullah Bin Khalid; Syed Ahsan; Wasim Jafri; Saeed Hamid; Anam Javed; Sana Wahab
Journal:  Pak J Med Sci       Date:  2014 Nov-Dec       Impact factor: 1.088

Review 6.  Interaction between microbiota and immunity and its implication in colorectal cancer.

Authors:  Changsheng Xing; Yang Du; Tianhao Duan; Kelly Nim; Junjun Chu; Helen Y Wang; Rong-Fu Wang
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

7.  Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study-CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study I.

Authors:  Takuya Yoshino; Hiroshi Nakase; Tomohisa Takagi; Shigeki Bamba; Yusuke Okuyama; Takuji Kawamura; Teruki Oki; Hirozumi Obata; Chiharu Kawanami; Shinji Katsushima; Toshihiro Kusaka; Tomoyuki Tsujikawa; Yuji Naito; Akira Andoh; Takafumi Kogawa
Journal:  BMJ Open Gastroenterol       Date:  2016-11-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.